Nxstage Medical (NXTM) Tops Q2 EPS by 1c

August 4, 2016 8:52 AM EDT

Nxstage Medical (NASDAQ: NXTM) reported Q2 EPS of ($0.03), $0.01 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $92.2 million versus the consensus estimate of $89.44 million.

GUIDANCE:

Nxstage Medical sees FY2016 revenue of $360-365 million, versus the consensus of $359.9 million.

For earnings history and earnings-related data on Nxstage Medical (NXTM) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings